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Most human pyelonephritogenic Escherichia coli express the
PapG II adhesin. However, the role of the PapG II adhesin in
enhancing the establishment and persistence of E. coli
infection in the kidney is controversial. A pyelonephritogenic
strain, EC114, which possesses one copy of the papG II gene,
but without other virulence factors (such as S/F1C-fimbriae,
hemolysin, and cytotoxic necrotizing factor 1) was selected
for the construction of a papG II mutant. The resulting papG II
mutant was confirmed by polymerase chain reaction,
Southern hybridization, and agglutination assay, and
designated as MEC114. We compared MEC114 with the
parental strain (EC114) for colonization ability in the bladder
and kidney of female BALB/c mice, which were challenged
transurethrally with 50 ll of a low (5 104 CFU (colony-
forming unit)) or high (5 108 CFU) dose of EC114 or MEC114
and assessed 1, 3, and 7 days after inoculation. Geometric
means of quantitative bacterial counts in the kidney were
significantly decreased when challenged with MEC114 on day
3 after inoculation, at both low and high dose (Po0.05), as
compared with EC114. On the seventh day, both strains were
mainly cleared from the kidney. Renal biopsy showed a
similar degree of inflammatory response to both strains 1, 3,
and 7 days after inoculation. In brief, the PapG II adhesin can
enhance the early establishment of E. coli infection in the
kidney, but the bacteria do not maintain infection owing to
the host immune response.
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Among the various types of fimbriae or adhesins of
Escherichia coli, P-fimbriae are significantly associated with
renal infection, especially for children and adult women with
non-obstructive renal infection.1–5 However, the role of
P-fimbriae in bacterial colonization of the urinary tract,
especially kidneys, is less clear because P-fimbriated E. coli
strains confer an advantage in some animal models,6–8 but
not in others.9–11
The receptor-binding PapG adhesin is located at the tip of
P-fimbriae,12 and the receptors for the PapG adhesin are
present on uroepithelial cells of human, primates, and
mice.13–15 Three classes (I–III) of PapG adhesins that have
been identified are encoded by papG I–III, respectively.16
These adhesins display high affinity recognition of three
different a-D-gal-1-4-b-D-gal containing isoreceptors.17,18
Most human pyelonephritogenic E. coli express the PapG II
adhesin, which recognizes the major a-D-gal-1-4-b-D-gal
globoside-containing isoreceptor of the human kidney.17
Our previous studies have demonstrated that among the
three classes of papG genes, only the class II papG is
associated with upper urinary tract infection (UTI).19,20
P-fimbriae with PapG II and/or III adhesins can enhance the
early establishment of bacteriuria in the human urinary
tract.21 Thus, we tried to assess whether the PapG II adhesin
can enhance the establishment and persistence of E. coli in
the kidney, and whether the adhesin contributes to the
pathogenicity of E. coli in acute pyelonephritis (APN).
In vitro studies have shown that papG mutants can express
morphologically normal pili that, however, cannot bind to
a-D-gal-1-4-b-D-gal (Gal-Gal)-containing receptors in
vitro.12,22,23 Therefore, we constructed an isogenic papG II
mutant, which was unable to produce the PapG II adhesin.
The resulting mutant was compared to the parental strain for
the ability to colonize the bladder and kidneys of mice. These
comparisons utilized the ascending UTI model of BALB/c
mice, which can express receptors (a-D-gal-1-4-b-D-gal
analogous) for the PapG II adhesin in the mucosa of bladder
and kidney.14
The present investigations differ somewhat in their
approach from previous reports.6–8 We have utilized a clinical
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isolate devoid of all other known adhesins of uropathogenic
E. coli except Type 1 fimbriae, and constructed a deletion of
the gene encoding the PapG II adhesin whereas leaving the
rest of the operon intact and capable of expressing P-fimbriae
devoid of the adhesive subunit. In addition, we quantitatively
recovered the bacteria from the mice’s bladder and kidney 1,
3, and 7 days after inoculation to investigate the role of the
PapG II adhesin in the establishment and persistence of
E. coli in the bladder and kidney. Thus our approach might
be clearer than previous studies and can directly test the role
of the PapG II adhesin.
RESULTS
Genetic analysis of the papG II mutant
A papG II mutant was isolated by allelic exchange. After
conjugative transfer of pMW353 from SM10lpir into EC114,
a single colony developed that displayed ampicillin resistance.
Bacteria from the colony were grown in the presence of 5%
sucrose. Of 100 sucrose-resistant colonies, 10 were found to
be sensitive to ampicillin, suggesting that loss of the suicide
vector sequence had occurred. One of the 10 ampicillin-
sensitive and sucrose-resistant colonies was further con-
firmed by polymerase chain reaction (PCR) and Southern
blot analysis (Figure 1).
We first confirmed that the size of the papG II region had
increased as a result of the insertion of the 806-bp HinCII
chloramphenicol cassette within the gene. Using primer pair
A, near the 50 and 30 ends of the papG II gene, a 979-bp
product was amplified from EC114 (Figure 1a). In contrast,
the product obtained from the mutant strain was 1.78 kb
(Figure 1a). Primer pair B, flanking a 194-bp DNA fragment
and containing the NruI site of EC114 papG II, was used to
double check the PCR results. A 194-bp product was
amplified from EC114, whereas a 1-kb product was amplified
from the mutant strain (Figure 1a). Both PCR results were
consistent with the insertion of an 806-bp HinCII chloram-
phenicol cassette into the NruI site of the papG II gene of the
mutant strain. Results of Southern hybridization confirmed
the above finding (Figure 1b). The probe hybridized to a
smaller HaeII fragment (549 bp) from EC114, and hybridized
to a larger fragment (1.35 kb) from the MEC114 mutant
strain (Figure 1b).
Phenotype characterization of the isogenic mutant
The wild-type EC114 and isogenic mutant MEC114 displayed
similar colony morphologies, antibiotic resistance patterns
(except the chloramphenicol resistance in mutant), and
plasmid profiles (data not shown). The expression of the
PapG II adhesin was compared in the wild-type, mutant, and
complemented mutant strains (Table 1). MEC114 did not
agglutinate human blood types A1P1 or OP1, or sheep
erythrocytes, whereas EC114 and the complemented strain
were mannose-resistant hemagglutination positive for all
three erythrocyte types. The mannose-resistant hemaggluti-
nation results were consistent with the mutation of the papG
II gene in MEC114. In addition, the wild type, mutant, and
complemented mutant all expressed mannose-sensitive
hemagglutination to guinea-pig erythrocytes, indicating
expression of Type 1 fimbriae (Table 1).
Virulence in the BALB/c mouse model of ascending UTI
When challenged with a low dose of bacteria (5 104 CFU),
colonization of the kidney (X103 CFU in kidney) with wild-
type strain EC114 occurred after 1 day in 30% of the mice
and after 3 days in 60% of the mice (Figure 2a). In contrast,
the percentages of kidney colonization were 10% on day 1
and 10% on day 3 for the papG II mutant (Figure 2a). The
percentage of kidney colonization was higher in the EC114
group on day 3 after inoculation, with a borderline P-value
(P¼ 0.057). The geometric means of quantitative bacterial
counts in MEC114-infected kidneys were significantly less
than the counts in EC114-infected kidneys on the third day
after inoculation (Po0.05) (Figure 2c). Seven days after
bacterial challenge, E. coli had been essentially cleared from1.4 kb
1.35 kb
549 kb600 bp
1 kb
Marker MarkerEC114 EC114EC114MEC114 MEC114MEC114
a b
Figure 1 | PCR analysis and Southern hybridization confirmation
of the insertion mutation in the papG II gene of MEC114. (a) PCR
analysis. Primer pair B amplified a 190-bp DNA fragment from EC114
(Lane 1), whereas a 996-bp product was evident from MEC114 (Lane
2). Primer pair A amplified a 979-bp product from EC114 (Lane 3). The
product obtained from MEC114 was 1.78 kb (Lane 4). (b) Southern
blot. Chromosomal DNA, isolated from E. coli EC114 and its isogenic
mutant MEC114, was digested with HaeII. The probe hybridized to a
smaller HaeII fragment (549 bp) from EC114 and to a larger fragment
(1.35 kb) from MEC114. PCR and Southern hybridization results
confirmed that a 806-bp HinCII chloramphenicol cassette was
inserted to the papG II gene of the mutant strain MEC114.
Table 1 | The results of hemagglutination tests of the
wild-type, mutant, and complemented mutant strains
Wild-type
EC114
Mutant
MEC114
Complemented
mutant
MRHA (P-fimbrae PapG II adhesin)
Human A1P1 RBCs +  +
Human OP1 RBCs +  +
Sheep RBCs +  +
MSHA (Type 1 fimbriae)
Guinea-pig RBCs + + +
MRHA, mannose-resistant hemagglutination; MSHA, mannose-sensitive hemag-
glutination; RBCs, red blood cells.
Notes: MRHA to human types A1P1 and OP1, and sheep RBCs indicate expression of
PapG II adhesin; MSHA to guinea-pig RBCs indicates expression of type 1 fimbriae.
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the examined kidneys; colonization rates of EC114 and
MEC114 were 20 and 0%, respectively.
When challenged with a high dose of E. coli EC114
(5 108 CFU), kidney colonization reached 70% by day 1,
and remained at the same level through day 3 (Figure 2b).
In contrast, colonization by the same challenge dose of
mutant MEC114 was 20% after day 1 and 10% after day 3
(Figure 2b). The percentage of kidney colonization was
higher in the EC114 group on day 3 after inoculation
(Po0.05). The geometric means of quantitative bacterial
counts in MEC114-infected kidneys were significantly less
than the counts in EC114-infected kidneys on the third day
after inoculation (Po0.05) (Figure 2d). Similar to low dose
inoculation, the infecting E. coli were cleared from the mouse
kidney by the seventh day following challenge. The kidney
colonization rates of EC114 and MEC114 were 10 and 0%,
respectively.
There was no significant temporal or dose-related
difference in the percentage of bladder colonization or
bacterial counts in mouse bladders between the tested strains
(Figure 3a–d).
When inoculated with the low dose of E. coli, two mice
(one challenged with EC114, and the other challenged with
MEC114) developed bacteremia. At the higher challenge
dose, three mice challenged with EC114 and three mice
challenged with MEC114 developed bacteremia on day 1 or 3
(data not shown).
Renal biopsy
The mean renal pathological scores were similar between the
wild-type and mutant strains at both challenge doses and all
time points (Figure 4). On days 1 and 3 after challenge, acute,
mild to severe pyelitis and acute, mild to moderate
pyelonephritis were found in both groups of mice infected
with EC114 and MEC114, and the infiltrated inflammatory
cells were predominately neutrophils (Figure 5a). Whereas on
day 7 after infection, more chronic pyelitis and pyelonephritis
were found in both groups of mice infected with EC114 and
MEC114, and the infiltrated inflammatory cells were
predominately mononuclear cells (Figure 5b).
DISCUSSION
Non-adherent P-fimbrial mutants of E. coli have been
assessed for virulence in several reports. Slight attenuation
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Figure 2 | Percentage of kidney colonization and geometric
means of quantitative bacterial counts in BALB/c mice kidney.
Each mouse was challenged transurethrally with bacterial
suspensions (low dose: (a) and (c) 5 104 CFU or (b) and (d) high
dose: 5 108 CFU) of wild-type E. coli EC114 (~) or isogenic mutant
MEC114 (m). Ten mice in each group and a total of 120 mice were
inoculated. (a and b) The percentage of kidney colonization (defined
as X103 CFU in kidney) were higher in EC114 group on day 3 after
inoculation (#P¼ 0.057; *Po0.05). Each point in (c and d) represents
the geometric value of bacterial count (Log10 CFU) per kidney from
individual mice. Each horizontal line represent the geometric mean
(n¼ 10) of the bacterial counts. The geometric means of quantitative
bacterial counts in the kidney were significantly different (*Po0.05)
on day 3 after inoculation, irrespective of the challenge dose (high or
low).
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Figure 3 | Percentage of bladder colonization and geometric
means of quantitative bacterial counts in BALB/c mouse bladder.
Each mouse was challenged transurethrally with (a and c) 5 104 CFU
or (b and d) 5 108 CFU of EC114 (~) or MEC114 (m). Ten mice in
each group and a total of 120 mice were inoculated. (a and b) The
percentage of Bladder colonization was defined as X103 CFU in
bladder. Each point in (c and d) represents the geometric value of
bacterial count (Log10 CFU) per bladder from individual mice. Each
horizontal line represent the geometric mean (n¼ 10) of the bacterial
counts. There were no temporal- or dose-related significant
differences in colonization rate or geometric means of quantitative
bacterial counts between the strains EC114 and MEC114.
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was observed for one strain in the monkey,6 and no difference
in virulence was observed for another APN strain in mice.9
We screened 81 APN strains that were assessed by PCR and
possessed a minimal number of virulence factors. One strain
was picked that had aerobactin, Type 1 fimbria, and one copy
of pap (papG II), but not other traditional virulence
determinants. Analyses conducted 1, 3, and 7 days following
the inoculation of wild-type (EC114) or mutant (MEC114)
E. coli into the urinary tract of mice allowed the assessment of
the role of the PapG II adhesin in kidney colonization and
subsequent persistence of the bacteria. We demonstrate that
the PapG II adhesin enhances the early (by day 3) kidney
colonization, but it does not enhance bacterial persistence.
PapG II adhesin may confer the ability to colonize the kidney,
at least transiently.
In 1993, Mobley et al.9 constructed a double P-fimbrial
mutant of a virulent clinical isolate (CFT073) to test the role
of P-fimbriae in a mouse model of APN. Their results
supported the hypothesis that adherence mediated by the
P-fimbrial adhesin plays only a subtle role in the development
of APN. One interpretation for these unexpected results is
that this isolate possesses additional virulence factors such as
S-fimbriae and hemolysin, which are sufficient to cause APN
in the absence of P-fimbrial adhesin class II. In our study, we
selected the pyelonephritogenic E. coli strain EC114, to
directly investigate the role of the PapG II adhesin in APN.
EC114 displays a positive papG II genotype and encodes a
functional PapG II adhesin and Type 1 fimbriae; however,
this strain lacks the genetic determinants of S/F1C-fimbriae,
afimbrial adhesins, hemolysin, and cytotoxic necrotizing
factor 1. Use of this strain can clearly demonstrate that the
PapG II adhesin significantly enhances the colonization
ability of E. coli in kidney on the third day after inoculation
of bacteria into the urinary tract.
Previous studies show that fimbriae-mediated attachment
enhances host cytokine responses to uropathogenic E. coli,
and that isolated P- or Type 1 fimbriae can activate receptor-
bearing epithelial cells.24 The signal pathways of inflam-
matory responses induced by the P- and Type 1-fimbriae-
mediated attachment are different,25 whereas, both can
activate the receptor-bearing epithelial cells, resulting in the
release of interleukin-6 and -8 and subsequent recruitment of
neutrophils.25,26 Although the wild-type strain EC114
displayed enhanced kidney colonization compared to mutant
MEC114, both strains can induce the inflammatory response
of kidney epithelium. A higher proportion of infecting EC114
cells were cleared from the mice’s kidney by 7 days after
challenge, which might be due to an inflammatory response
induced by the bacteria themselves. Our mutant strain is
defective in a PapG II-mediated inflammatory response.
However, mannose-containing receptors are also found in the
renal epithelium of BALB/c mice,14 and our mutant strain
has a fim gene, and so can express the Type 1 fimbriae. Thus,
Type 1 fimbriae-mediated cytokine responses can also induce
an inflammatory response in kidney in the mice infected by
the mutant strain. In normal mice, microorganisms are
cleared by the immune response within 7 days after
infection.27 Our results are compatible with this finding;
both the wild-type and mutant strains were mostly cleared
from infected kidneys via an immune response triggered by
P-fimbriae, Type 1-fimbriae, or other unknown factors
within 7 days after inoculation.
Ascent of inoculated bacteria from bladder through the
ureter to the mouse kidney without artificial vesico-ureteral
reflux might need a period of time, and might be enhanced
by the PapG II adhesin. Rice et al.8 identified another possible
virulence mechanism of E. coli that express P-fimbriae. They
found that P-fimbriae can decrease polymeric immuno-
globulin receptor expression in the kidney and consequently
decrease immunoglobulin A transport into the urinary space.
And, there was a significant effect of P-fimbriae on the ability
of bacteria to establish infection in mice kidney at the early
stage of infection (i.e. 6 and 48 h after inoculation of bacteria
into mice bladder).8 In addition to increased adhesion, this
novel virulence mechanism can explain why the P-fimbriae
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Figure 4 | Renal pathological findings. Scores are obtained from the
histological evaluation of kidney sectioned through the middle part
containing papilla, medulla and cortex, and stained with hematoxylin
and eosin in mice inoculated with low (5 104 CFU) or high
(5 108 CFU) doses of EC114 and MEC114 suspensions on days 1, 3,
and 7 after challenge. The mean renal pathological scores were
similar between the two groups.
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Figure 5 | Representative pictures of renal pathology:
inflammatory changes in kidney. Sections were stained with
hematoxylin and eosin. (a) Acute, severe pyelitis in a mouse
inoculated with 108 CFU of strain EC114 on day 3. The flattened
pelvocalyceal epithelium (PE) and subepithelial tissue (SE) are
infiltrated with neutrophils (arrows). Aggregates of neutrophils within
the pelvic lumen (PL) are also noted (right lower corner) (original
magnification,  400). (b) More chronic pyelitis in a mouse
inoculated with 108 CFU of strain MEC114 on day 7. There are
abundant mononuclear cells (arrows), predominantly lymphocytes
and macrophages infiltrating in the PE and SE (original magnification,
 400).
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can enhance the early establishment of E. coli in the mouse
urinary tract.
More virulent uropathogenic E. coli strains may cause an
earlier establishment of kidney colonization, even as early as
4–6 h post-inoculation. In our study, where an E. coli strain
with relatively lower virulence was used, the establishment of
kidney colonization may be later, and most of the mice (112/
120) did not develop bacteremia during the course of
infection.
The persistence of the wild-type and mutant strains in the
bladder was not significantly different, perhaps reflective of
the expression of Type 1 fimbriae by both strains. Indeed,
70% of urinary isolates of E. coli possess Type 1 fimbriae,
which bind to a mannose containing receptor.28 Moreover,
D-mannose-incorporating glycoproteins are widely expressed
by mucosal cells in the lower urinary tract, and more
intensely in the bladder epithelium than in the kidney
epithelium of BALB/c mouse.14,29 Furthermore, bacteria were
not eliminated from the bladder by the immune response of
bladder mucosa after 7 days of inoculation. The strength of
the immune responses might thus differ between the mouse
bladder and kidney.
In 2000, Wullt et al.21 reported on the transformation of
an asymptomatic E. coli, strain 83972, with papG II/papGIII
genes cloned into pREG153/pGE523. The results showed the
papG II/papGIII transformants establish bacteriuria more
rapidly than the parental E. coli 83972. These results
suggested that P-fimbrial adhesins enhance the establishment
of bacteriuria in the human urinary tract. However, the above
experiment did not directly evaluate the estiablishment of
E. coli in the kidney. Our present study demonstrates that the
PapG II adhesin enhances the early establishment of E. coli
infections in the kidney. But persistence of kidney infection
may depend, at least in part, on bacterial resistance to the
host immune system.
This study enhances our understanding of pathogenesis of
APN and supports that blocking the interaction between the
PapG II adhesin of E. coli and its receptors can inhibit the
early establishment of bacteria in the kidney. This interaction
may prove to be instructive in the development of
preventative strategies for APN patients.
MATERIALS AND METHODS
Bacterial strains and plasmids
Eighty-one clinical E. coli strains isolated from APN patients at
National Cheng Kung University Medical Center were screened for
virulence genes and phenotypes. A strain, EC114, having the PapG II
adhesin genotypically and phenotypically, but without other
virulence factors, such as S/F1C-fimbriae, afimbrial adhesins,
hemolysin, and cytotoxic necrotizing factor 1, was selected for
construction of the papG II mutant (Table 2). EC114 is ampicillin
sensitive (the selective marker of the suicide vector pCVD442)
and tetracycline resistant. As almost all of our APN strains possessed
the genetic determinants of Type 1 fimbriae (fimH) and aerobactin
receptor (iutA),19,20 EC114 also has the fimH and iutA genes.
We analyzed restricted chromosomal DNA from EC114 via South-
ern hybridization, using a probe specific for the papG II gene,
and revealed that EC114 carried only one copy of pap (data not
shown).
E. coli strain SY327lpir, was the host for transformation of
pCVD442 and pCVD442-derived plasmids.30,31 SM10lpir was used
as the donor strain in mating involving the suicide vector.32 E. coli
DH5a (Bethesda Research Labs., Gaithersburg, MD, USA) was the
host strain for transformation of other plasmids. Bacteria were
cultured in Luria broth (LB) or on LB-agar plates. Ampicillin
(100 mg/ml), tetracycline (5mg/ml) and chloramphenicol (25 mg/ml)
were added as appropriate. pGEM-T easy vector (Promega,
Madison, WI, USA) was used for cloning the entire papG II gene.
Plasmid pCVD442 is a R6K-based suicide vector containing the
selectable Ampr and counterselectable sacB markers, along with the
mobilization sequence mobRP4.31 Plasmid pUC18 was used for
expression of PapG II adhesin.
Testing for P- and Type 1 fimbrial phenotypes
The hemagglutination assay used for evaluation of expression of the
PapG II and Type 1 fimbrial adhesins has been described
previously.33 Expression of the PapG II adhesin was indicated by
mannose-resistant hemagglutination to human types A1P1 and
OP1, and sheep erythrocytes. Mannose-sensitive hemagglutination
to guinea-pig erythrocytes indicated expression of Type 1 fimbriae.
Construction of papG II insertion mutant and
complementation strains
DNA modification. Preparation of plasmid DNA and plasmid
transformations were performed using standard methods.34
Construction of pMW353 containing a papG II fragment with an
insertion mutation. PCR primers complementary to the sequence
immediate to the 50 and 30 ends of the previously sequenced papG
class II gene (from E. coli strain IA2, accession number M20181)
were designed for amplification of the EC114 papG II gene.35 Their
sequences were as follows: papG II 12f, 50-gttcccagctttgttattttcc-30;
papG II 990r, 50-tgctgaaccagatagtactcc-30. The PCR product, papG II
979, encompasses almost the entire papG II gene (12–990, totally 979
of 1014 bp). A 806-bp HinCII DNA fragment of a chloramphenicol
cassette (Accession number M35190)36 was ligated into the
phosphatase-treated NruI site (flanking papG II at nucleotide 553)
of papG II 979. The insertion mutation fragment of papG II 979 was
cut out of the T-easy vector at the EcoRI site, which was treated to
become blunt-ended, and ligated into the phosphatase-treated SmaI
site of pCVD442 to create pMW353. Plasmid pMW353 was
propagated in E. coli strain SY327lpir for mating and allelic
exchange.
Mating and selection of papG II insertion mutants. Plasmid
pMW353 was introduced into EC114 from SM10lpir by filter
Table 2 | Virulence factors of Escherichia coli strain EC114
Virulence factor EC114
papG Class I (P-fimbriae Class I PapG adhesin) Negative
papG Class II (P-fimbriae Class II PapG adhesin) Positivea
papG Class III (P-fimbriae Class III PapG adhesin) Negative
fimH (Type 1 fimbriae) Positivea
sfa (S-fimbriae) Negative
foc (F1C-fimbriae) Negative
afa (Afimbrial adhesins) Negative
iutA (Aerobactin receptor) Positive
hlyA (Hemolysin) Negative
cnf1 (Cytotoxic necrotizing factor 1) Negative
aPositive in genotype and phenotype.
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mating, with selection for ampicillin resistance. From overnight LB
cultures containing appropriate antibiotics, donor (SM10lpir) and
recipient (EC114) were incubated into LB at respective dilutions of
1:40 and 1:20. Growth at 371C for 2.5 h preceded mixing of 1 ml of
donor with 0.5 ml of recipient. The mixed suspension was filtered
through sterile 0.45mm Millipore (Millipore Corporation, Bedford,
MA, USA) filters. Filters were placed on LB agar, incubated at 371C
for 2 h, and then placed in a tube containing 2 ml of LB. Cells were
removed from the filter by vortexing and 0.1 ml of the resultant
suspension was plated onto LB agar containing ampicillin for
incubation (18 h, 371C). Colonies were picked, inoculated into LB,
and cultured for 5 h at 371C. From this culture, 0.1 ml of 105, 106,
and 107 dilutions were plated onto sodium chloride-free LB agar
with and without 5% (w/v) sucrose. Sucrose-resistant colonies were
picked and tested for ampicillin sensitivity, indicative of the loss of
suicide vector sequences. Such colonies were tested for the insertion
mutation of the papG II gene by PCR and Southern hybridization.
PCR analysis. Primers (pair A; whose sequence is described
above) near the 50 and 30 ends of the papG II gene were used to
amplify a 979-bp product from wild type strain and a 1.78-kb
fragment from the mutant strain. A second primer pair (B) flanking
a 194-bp DNA fragment and containing the NruI site of EC114
papG II was used to double check the PCR results. The sequences of
pair B were papG II 383f: 50-gggatgagcgggcctttgat-30 and papG II
572r: 50-cgggcccccaagtaactcg-30.
Southern blot hybridization. Chromosomal DNA was ex-
tracted as previously described and digested with the restriction
enzyme HaeII.37 PCR products of the 979-bp DNA fragment from
the EC114 papG II gene were used as DNA probe. The probe
contained the papG II NruI site where the chloramphenicol cassette
was inserted. Labeling of probes and detection of fragments after
hybridization were performed using the Gene Images AlkPhos
Direct Labeling and Detection system (Amersham Biosciences,
Freiburg, Germany), according to the manufacturer’s instructions.
Complementation. BamHI sites were added to the 50 and
30 ends of the 1514-bp PCR product of papG II gene and its 500-bp
upstream sequence, flanking the papF gene at mucleotide 679
(Accession number M 20181).35 This fragment was ligated into the
BamHI site of plasmid pUC18 to create plasmid pUC18HpapFG II
for expression of the PapG II adhesin. The plasmid pUC18HpapFG
II was transformed into the papG II mutant strain to further confirm
that the mutation of the papG II gene was precise and could be
complemented. The wild-type (parent) strain, mutant strain, and
complemented strain were compared for PapG II adhesin phenotype
expression.
Mouse model of ascending UTI
Bacteria from frozen stocks were cultured in nutrient broth for 48 h
at 371C, harvested by centrifugation, and adjusted to the desired
concentration in normal saline. The mouse model of ascending UTI
was based on that of Hagberg et al.38 with modification.39 Totally,
120 female BALB/c mice, aged 6–8 weeks, were anesthetized with
pentobarbital intraperitoneally. The peritoneum was disinfected and
a polyethylene catheter (PE10, Intramedic, Becton-Dickinson,
Sparks, MD, USA), with the internal diameter: 0.28 mm, outer
diameter: 0.61 mm,B25 mm long, was inserted through the urethra
orifice into the bladder until resistance was felt, then withdrawn
several mm. Fifty ml of bacterial suspension, containing 5 104 or
5 108 CFU/ml of the parental or mutant E. coli bacteria was
inoculated via the catheter. Mice were sacrificed 1, 3, or 7 days after
the bacterial challenge. Upon killing, urine and blood were
aspirated, and both the left kidney and bladder were removed and
homogenized aseptically for quantitative culture.
Histological examination
Upon sacrifice, the right kidney was removed, preserved in 10%
formalin, and sectioned through its central region, which contains
papilla, medulla, and cortex. Sections were stained with hematoxylin
and eosin and evaluated in a blind manner by a pathologist. The
severity of renal pathology was graded with a scoring system in
which 0, 1þ , 2þ , 3þ indicated normal, mild, moderate, and
severe pyelitis, respectively; 4þ , 5þ , 6þ indicated mild, moderate,
and severe pyelonephritis, respectively. For each group, two of the
mice’s kidneys successfully colonized by the introduced E. coli were
evaluated for pathological change. If more than two mice were
infected in each group, two of the more severely infected mouse
kidneys (i.e. higher quantitative bacterial culture) were evaluated.
For each group, the pathological severity was presented as the mean
pathological score.
Statistical analyses
Quantitative culture results were logarithmically transformed for
statistical analyses. Mean numbers of CFU per bladder or kidney
from culture of tissue homogenates were compared by the Student’s
t-test. Differences in the numbers of mice with bladder or kidney
colonized by the challenge organisms were compared by the Fisher’s
exact or w2 tests when appropriate.
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